TrovaGene Inc. | Mutual Funds
Mutual Funds that own TrovaGene Inc.
Vanguard Extended Market Index Fund
192,747
1.09%
157,638
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
96,661
0.55%
87,872
0%
07/31/2018
4,531
0.03%
0
0.01%
09/05/2018
Fidelity Spartan Total Market Index Fund
2,821
0.02%
0
0%
07/31/2018
Vanguard Balanced Index Fund
2,468
0.01%
0
0%
07/31/2018
Meeder Spectrum Fund
2,253
0.01%
1,800
0%
06/29/2018
Vanguard Total Stock Market Index Fund
1,176
0.01%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
1,130
0.01%
0
0%
09/06/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
509
0%
1
0%
06/30/2018
BlackRock Master Extended Market Index Series
460
0%
0
0%
01/31/2018
| Address |
11055 Flintkote Avenue
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.trovagene.com |
| Updated |
07/08/2019 |
| Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M. |
